Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
Sil Kordes(Academic Medical Center), Johanna W. Wilmink(Amsterdam University Medical Centers), Ron A. A. Mathôt(Amsterdam University Medical Centers), Cornelis J.A. Punt(Utrecht University), Aeilko H. Zwinderman(Amsterdam Neuroscience), Mariëtte J. Weterman(Academic Medical Center), Michaël Pollak(McGill University), Dick J. Richel(Amsterdam UMC Location University of Amsterdam), Aart Beeker(Spaarne Ziekenhuis)
Cited by 380
Related Papers
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews
|Journal of Clinical Epidemiology|2005|3.3k
Circulating concentrations of insulin-like growth factor I and risk of breast cancer
|The Lancet|1998|1.8k
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
|New England Journal of Medicine|2008|1.2k
Direct detection of early-stage cancers using circulating tumor DNA
|Science Translational Medicine|2017|1.1k
The Athlete’s Heart
|Circulation|2000|1.1k